Background In the 5 years that have passed since the publication of the 2018 International
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …

Allergen immunotherapy is a cornerstone in the treatment of allergic children. The clinical
efficiency relies on a well‐defined immunologic mechanism promoting regulatory T cells and …

Background Critical examination of the quality and validity of available allergic rhinitis (AR)
literature is necessary to improve understanding and to appropriately translate this …

It is estimated that more than 339 million people worldwide suffer from asthma. The leading
cause of asthma development is the breakdown of immune tolerance to inhaled allergens …

Objective Allergic rhinitis (AR) is one of the most common diseases affecting adults. It is the
most common chronic disease in children in the United States today and the fifth most …

Background: The persistently high prevalence of allergic diseases in Western industrial
nations and the limited possibilities of causal therapy make evidence-based …

Allergic diseases are common and frequently coexist. Allergen immunotherapy (AIT) is a
disease‐modifying treatment for IgE‐mediated allergic disease with effects beyond …

Allergic rhinitis is a symptomatic disorder of the nose induced after allergen exposure by an
immunoglobulin E (IgE)-mediated inflammation of the membranes lining the nose (1). It was …

These parameters were developed by the Joint Task Force on Practice Parameters,
representing the American Academy of Allergy, Asthma & Immunology; the American …

Background: 3‐year subcutaneous specific immunotherapy (SIT) in children with seasonal
allergic rhinoconjunctivitis reduced the risk of developing asthma during treatment and 2 …